Vikas Sinha - Net Worth and Insider Trading
Vikas Sinha Net Worth
The estimated net worth of Vikas Sinha is at least $82 Million dollars as of 2026-08-11. Vikas Sinha is the EVP & CFO of Alexion Pharmaceuticals Inc and owns about 178,463 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $33 Million. Vikas Sinha is the CFO of Scholar Rock Holding Corp and owns about 619,856 shares of Scholar Rock Holding Corp (SRRK) stock worth over $32 Million. Vikas Sinha is also the Director of Verona Pharma PLC and owns about 94,112 shares of Verona Pharma PLC (VRNA) stock worth over $10 Million. Besides these, Vikas Sinha also holds AlloVir Inc (ALVR) . Details can be seen in Vikas Sinha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vikas Sinha has not made any transactions after 2026-04-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vikas Sinha
Vikas Sinha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vikas Sinha owns 6 companies in total, including AlloVir Inc (ALVR) , Alexion Pharmaceuticals Inc (ALXN) , and BCLS Acquisition Corp (BLSA) among others .
Click here to see the complete history of Vikas Sinha’s form 4 insider trades.
Insider Ownership Summary of Vikas Sinha
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALVR | AlloVir Inc | 2025-02-21 | director & 10 percent owner & See Remarks |
| ALXN | Alexion Pharmaceuticals Inc | 2016-08-08 | EVP & CFO |
| BLSA | BCLS Acquisition Corp | 2020-10-22 | director |
 | | 2025-08-01 | director |
| | 2026-04-16 | Chief Financial Officer |
| | 2020-07-29 | director & 10 percent owner & See Remarks |
Vikas Sinha Latest Holdings Summary
Vikas Sinha currently owns a total of 4 stocks. Among these stocks, Vikas Sinha owns 178,463 shares of Alexion Pharmaceuticals Inc (ALXN) as of August 8, 2016, with a value of $33 Million and a weighting of 39.53%. Vikas Sinha owns 619,856 shares of Scholar Rock Holding Corp (SRRK) as of April 16, 2026, with a value of $32 Million and a weighting of 39.04%. Vikas Sinha also owns 94,112 shares of Verona Pharma PLC (VRNA) as of August 1, 2025, with a value of $10 Million and a weighting of 12.21%. The other 1 stocks AlloVir Inc (ALVR) have a combined weighting of 9.22% among all his current holdings.
Latest Holdings of Vikas Sinha
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2016-08-08 | 178,463 | 182.50 | 32,569,498 |
| SRRK | Scholar Rock Holding Corp | 2026-04-16 | 619,856 | 51.89 | 32,164,328 |
| VRNA | Verona Pharma PLC | 2025-08-01 | 94,112 | 106.91 | 10,061,514 |
| ALVR | AlloVir Inc | 2025-02-21 | 774,118 | 9.81 | 7,594,098 |
Holding Weightings of Vikas Sinha
Vikas Sinha Form 4 Trading Tracker
According to the SEC Form 4 filings, Vikas Sinha has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 277 shares on August 8, 2016, which brought Vikas Sinha around $37,988.
According to the SEC Form 4 filings, Vikas Sinha has made a total of 2 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Scholar Rock Holding Corp is the sale of 10,410 shares on April 16, 2026, which brought Vikas Sinha around $516,024.
According to the SEC Form 4 filings, Vikas Sinha has made a total of 4 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Verona Pharma PLC is the sale of 4,328 shares on August 1, 2025, which brought Vikas Sinha around $56,870.
More details on Vikas Sinha's insider transactions can be found in the Insider Trading History of Vikas Sinha table.Insider Trading History of Vikas Sinha
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Vikas Sinha Trading Performance
Vikas Sinha Ownership Network
Ownership Network List of Vikas Sinha
Ownership Network Relation of Vikas Sinha
Vikas Sinha Owned Company Details
What does AlloVir Inc do?
Who are the key executives at AlloVir Inc?
Vikas Sinha is the director & 10 percent owner & See Remarks of AlloVir Inc. Other key executives at AlloVir Inc include General Counsel Edward Miller , Chief Accounting Officer Brett R Hagen , and 10 percent owner Gilead Sciences, Inc. .
AlloVir Inc (ALVR) Insider Trades Summary
Over the past 18 months, Vikas Sinha made 1 insider transaction in AlloVir Inc (ALVR) with a net sale of 303. Other recent insider transactions involving AlloVir Inc (ALVR) include a net sale of 106 shares made by Edward Miller , a net sale of 96 shares made by Brett R Hagen ,
In summary, during the past 3 months, insiders sold 0 shares of AlloVir Inc (ALVR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 505 shares of AlloVir Inc (ALVR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 505 shares.
AlloVir Inc (ALVR)'s detailed insider trading history can be found in Insider Trading Tracker table.
AlloVir Inc Insider Transactions
Vikas Sinha Mailing Address
Above is the net worth, insider trading, and ownership report for Vikas Sinha. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Vikas Sinha's mailing address is: Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
